OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
34 hedge funds and large institutions have $7.3M invested in OncoSec Medical Incorporated in 2017 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 5 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
316% more capital invested
Capital invested by funds: $1.75M → $7.3M (+$5.54M)
280% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 5
70% more funds holding
Funds holding: 20 → 34 (+14)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.47M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$524K |
| 3 |
CLCM
Crawford Lake Capital Management
Lakewood,
New Jersey
|
+$472K |
| 4 |
Renaissance Technologies
New York
|
+$266K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$256K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.36M |
| 2 |
VF
Virtu Financial
New York
|
-$46K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$27K |
| 4 |
SMH
Sanders Morris Harris
Houston,
Texas
|
-$24K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$10K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| $4K | +$1.4K | +4 | +57% |
|
27
Citigroup
New York
| $2K | – | – | – |
|
|
WAP
28
Wealthcare Advisory Partners
West Chester,
Pennsylvania
| $2K | – | – | – |
|
29
Morgan Stanley
New York
| $2K | +$1.05K | +3 | +75% |
|
|
IA
30
IFP Advisors
Tampa,
Florida
| $2K | +$1.75K | +5 | New |
|
|
LTFS
31
Ladenburg Thalmann Financial Services
Miami,
Florida
| $2K | +$2.1K | +6 | New |
|
32
UBS Group
Zurich,
Switzerland
| $1K | – | – | – |
|
33
SEI Investments
Oaks,
Pennsylvania
| $1K | +$701 | +2 | New |
|
|
VF
34
Virtu Financial
New York
| – | -$46K | -217 | Closed |
|
|
35
Citadel Advisors
Miami,
Florida
| – | -$27K | -126 | Closed |
|
|
SMH
36
Sanders Morris Harris
Houston,
Texas
| – | -$24K | -114 | Closed |
|
|
TSS
37
Two Sigma Securities
New York
| – | -$10K | -50 | Closed |
|
38
JP Morgan Chase
New York
| – | -$1K | -3 | Closed |
|
ONCS Hedge Fund Activity: Q4 2017 in Review
34 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q4 2017, worth a combined $7.3M — up 316% from $1.75M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new ONCS positions and 5 closed out — a net gain of 14 holders — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $3.47M. The largest seller was Sabby Management, cutting an estimated $1.36M.
- 34 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q4 2017, up from 20 in Q3 2017.
- Funds reported $7.3M of OncoSec Medical Incorporated stock for Q4 2017, up 316% quarter-over-quarter.
- 19 funds opened new OncoSec Medical Incorporated positions in Q4 2017 and 5 closed out, a net change of +14 holders.
- The largest OncoSec Medical Incorporated buyer in Q4 2017 was Point72 Asset Management, an estimated $3.47M added.
- The largest OncoSec Medical Incorporated seller in Q4 2017 was Sabby Management, an estimated $1.36M sold.
Based on aggregated 13F filings for Q4 2017.